skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Predictive factors for exacerbation and reexacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort

Multidisciplinary respiratory medicine, 2019-12, Vol.14 [Peer Reviewed Journal]

2019. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1828-695X ;EISSN: 2049-6958 ;DOI: 10.4081/mrm.2019.6

Full text available

Citations Cited by
  • Title:
    Predictive factors for exacerbation and reexacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort
  • Author: Urwyler, Pascal ; Hussein, Nebal Abu ; Bridevaux, Pierre O. ; Chhajed, Prashant N. ; Geiser, Thomas ; Grendelmeier, Peter ; Zellweger, Ladina Joos ; Kohler, Malcolm ; Maier, Sabrina ; Miedinger, David ; Tamm, Michael ; Thurnheer, Robert ; Dieterle, Thomas ; Leuppi, Joerg D.
  • Subjects: Cardiovascular disease ; Chronic obstructive pulmonary disease ; Dyspnea ; Primary care
  • Is Part Of: Multidisciplinary respiratory medicine, 2019-12, Vol.14
  • Description: Background: The Swiss COPD cohort was established in 2006 to collect data in a primary care setting. The objective of this study was to evaluate possible predictive factors for exacerbation and re-exacerbation. Methods: In order to predict exacerbation until the next visit based on the knowledge of exacerbation since the last visit, a multistate model described by Therneau and Grambsch was performed. Results: Data of 1,247 patients (60.4% males, 46.6% current smokers) were analyzed, 268 (21.5%) did not fulfill spirometric diagnostic criteria for COPD. Data of 748 patients (63% males, 44.1% current smokers) were available for model analysis. In order to predict exacerbation an extended Cox Model was performed. Mean FEV1/FVC-ratio was 53.1% (±11.5), with a majority of patients in COPD GOLD classes 2 or 3. Hospitalization for any reason (HR1.7; P = 0.04) and pronounced dyspnea (HR for mMRC grade four 3.0; P < 0.001) at most recent visit as well as prescription of short-acting bronchodilators (HR1.7; P < 0.001), inhaled (HR1.2; P = 0.005) or systemic corticosteroids (HR1.8; P = 0.015) were significantly associated with exacerbation when having had no exacerbation at most recent visit. Higher FEV1/FVC (HR0.9; P = 0.008) and higher FEV1 values (HR0.9; P = 0.001) were protective. When already having had an exacerbation at the most recent visit, pronounced dyspnea (HR for mMRC grade 4 1.9; P = 0.026) and cerebrovascular insult (HR2.1; P = 0.003) were significantly associated with re-exacerbation. Physical activity (HR0.6; P = 0.031) and treatment with long-acting anticholinergics (HR0.7; P = 0.044) seemed to play a significant protective role. In a best subset model for exacerbation, higher FEV1 significantly reduced and occurrence of sputum increased the probability of exacerbation. In the same model for re-exacerbation, coronary heart disease increased and hospitalization at most recent visit seemed to reduce the risk for re-exacerbation. Conclusion: Our data confirmed well-established risk factors for exacerbations whilst analyzing their predictive association with exacerbation and re-exacerbation. This study confirmed the importance of spirometry in primary care, not only for diagnosis but also as a risk evaluation for possible future exacerbations. Trial registration: Our study got approval by local ethical committee in 2006 (EK Nr. 170/06) and was registered retrospectively on ClinicalTrials.gov (NCT02065921, 19th of February 2014).
  • Publisher: Pavia: PAGEPress Publications
  • Language: English;Italian
  • Identifier: ISSN: 1828-695X
    EISSN: 2049-6958
    DOI: 10.4081/mrm.2019.6
  • Source: PubMed Central
    ProQuest Central
    DOAJ Directory of Open Access Journals
    Springer Nature OA Free Journals

Searching Remote Databases, Please Wait